StemCell Institute Inc.

¥639.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:7096Healthcare
Country Japan
PE (Fwd) •••
TSR 5Y CAGR (20.16%)
Div yield —
ROE 4.59%
Biotechnology
Beta (5Y) 0.66
PE TTM 41.63
TSR TTM (21.60%)
Mkt cap ¥6.435B
ROIC 20.58%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥677
5.90%
9.79%
Hold 8|10|5|4|9
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
12.36
11.90
12.93
14.03
(3.26%)
(2.27%)
5.18%
12.74%
Revenue¥M
461.2
482.9
507.4
498.6
(0.83%)
5.43%
10.95%
10.97%
Peers (US$40.86M)
Cap (US$)
PE
38.31M
—
40.84M
—
Capital
TTM
5Y
10Y
Leveragex
1.470
0.019
0.018
EBIT/Intx
1.534
0.385
0.398
Own earn%
58.23
(8.25)
(2.12)
Sh yield%
26.79
27.72
25.46
Owners
Insiders/Inst%
10.96
81.71
Short interest%
1.54
SBC / revenue%
3.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
112